Monoclonal antibodies primed to become potent immune weapons against cancer

New research suggests that monoclonal antibody therapy of cancer can be improved to be much more powerful than it is today, says a researcher at Georgetown University Medical Center's Lombardi Comprehensive Cancer Center in the March 21 issue of the Lancet.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news156772110.html">Monoclonal antibodies primed to become potent immune weapons against cancer</a></p> <p>New research suggests that monoclonal antibody therapy of cancer can be improved to be much more powerful than it is today, says a researcher at Georgetown University Medical Center's Lombardi Comprehensive Cancer Center in the March 21 issue of the <i>Lancet</i>.</p>